Company profile for IGM Biosciences

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We are a biotechnology company pioneering the development of engineered IgM antibodies. IgM antibodies have inherent properties that we believe may enable them to improve upon the efficacy and safety of IgG antibodies in multiple therapeutic applications. We are a biotechnology company pioneering the development of engineered IgM antibodies. IgM antibodies have inherent properties that we believe may enable them to improve ...
We are a biotechnology company pioneering the development of engineered IgM antibodies. IgM antibodies have inherent properties that we believe may enable them to improve upon the efficacy and safety of IgG antibodies in multiple therapeutic applications. We are a biotechnology company pioneering the development of engineered IgM antibodies. IgM antibodies have inherent properties that we believe may enable them to improve upon the efficacy and safety of IgG antibodies in multiple therapeutic applications.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
325 East Middlefield Road Mountain View, CA 94043
Telephone
Telephone
(650) 965-7873
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/07/01/3108348/0/en/IGM-Biosciences-Enters-into-Agreement-to-Be-Acquired-by-Concentra-Biosciences-for-1-247-in-Cash-per-Share-Plus-a-Contingent-Value-Right.html

GLOBENEWSWIRE
01 Jul 2025

https://www.fiercebiotech.com/biotech/sanofi-axes-igm-pact-sparking-80-layoffs-and-facility-closures

FIERCE BIOTECH
09 May 2025

https://seekingalpha.com/news/4429532-igm-bio-stock-slips-bank-of-america-downgrades

SEEKINGALPHA
07 Apr 2025

https://www.fiercebiotech.com/biotech/igm-y-mabs-passage-bio-and-more-telegraph-staff-cuts-amid-pipeline-and-business-structure

FIERCE BIOTECH
10 Jan 2025

https://www.globenewswire.com/news-release/2025/01/09/3007285/0/en/IGM-Biosciences-Provides-Strategic-Update-on-Autoimmunity-Pipeline-Programs.html

GLOBENEWSWIRE
09 Jan 2025

https://www.globenewswire.com/news-release/2024/11/08/2977560/0/en/IGM-Biosciences-Announces-Third-Quarter-2024-Financial-Results-and-Provides-Corporate-Update.html

GLOBENEWSWIRE
08 Nov 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty